BrainsWay Reports Promising Pilot Study Results in Patients with Depression and Comorbid Early-Stage Alzheimer's Disease Treated with Deep TMS™

A peer-reviewed pilot study reported an 83.3% response rate and 50% remission rate for depressive symptoms, alongside measurable changes in brain activity and connectivity. The findings are encouraging for the underlying treatment approach, but the pilot-scale nature of the study limits near-term commercial and market implications.